A detailed history of Evermay Wealth Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Evermay Wealth Management LLC holds 133 shares of REGN stock, worth $95,318. This represents 0.02% of its overall portfolio holdings.

Number of Shares
133
Previous 133 -0.0%
Holding current value
$95,318
Previous $139,000 -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$902.69 - $993.35 $902 - $993
-1 Reduced 0.75%
133 $128,000
Q4 2023

Feb 09, 2024

BUY
$775.18 - $881.7 $103,874 - $118,147
134 New
134 $117,000
Q2 2021

Aug 13, 2021

BUY
$472.8 - $558.54 $33,096 - $39,097
70 New
70 $39,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.8B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Evermay Wealth Management LLC Portfolio

Follow Evermay Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evermay Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evermay Wealth Management LLC with notifications on news.